Učitavanje...
Treating C3 glomerulopathy with eculizumab
BACKGROUND: C3 glomerulopathy (C3G) is a rare, but severe glomerular disease with grim prognosis. The complex pathogenesis is just unfolding, and involves acquired as well as inherited dysregulation of the alternative pathway of the complement cascade. Currently, there is no established therapy. Tre...
Spremljeno u:
| Izdano u: | BMC Nephrol |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5767001/ https://ncbi.nlm.nih.gov/pubmed/29329521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0802-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|